Details
Stereochemistry | ACHIRAL |
Molecular Formula | C19H25N3.3C16H32O2 |
Molecular Weight | 1064.6941 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O.C(CN1CCCCC1)N(CC2=NC=CC=C2)C3=CC=CC=C3
InChI
InChIKey=RZGXZVBANSQIHQ-UHFFFAOYSA-N
InChI=1S/C19H25N3.3C16H32O2/c1-3-10-19(11-4-1)22(17-18-9-5-6-12-20-18)16-15-21-13-7-2-8-14-21;3*1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16(17)18/h1,3-6,9-12H,2,7-8,13-17H2;3*2-15H2,1H3,(H,17,18)
Sample Use Guides
In Vivo Use Guide
Sources: https://www.drugfuture.com/chemdata/Picoperine.html
LD50 orally in mice: 1900 mg/kg
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB03815MIG
Created by
admin on Fri Dec 15 18:37:57 GMT 2023 , Edited by admin on Fri Dec 15 18:37:57 GMT 2023
|
PRIMARY | |||
|
KQ0X5DIX9D
Created by
admin on Fri Dec 15 18:37:57 GMT 2023 , Edited by admin on Fri Dec 15 18:37:57 GMT 2023
|
PRIMARY | |||
|
100000085302
Created by
admin on Fri Dec 15 18:37:57 GMT 2023 , Edited by admin on Fri Dec 15 18:37:57 GMT 2023
|
PRIMARY | |||
|
DTXSID70179398
Created by
admin on Fri Dec 15 18:37:57 GMT 2023 , Edited by admin on Fri Dec 15 18:37:57 GMT 2023
|
PRIMARY | |||
|
m8786
Created by
admin on Fri Dec 15 18:37:57 GMT 2023 , Edited by admin on Fri Dec 15 18:37:57 GMT 2023
|
PRIMARY | Merck Index | ||
|
212686
Created by
admin on Fri Dec 15 18:37:57 GMT 2023 , Edited by admin on Fri Dec 15 18:37:57 GMT 2023
|
PRIMARY | |||
|
24656-22-2
Created by
admin on Fri Dec 15 18:37:57 GMT 2023 , Edited by admin on Fri Dec 15 18:37:57 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD